Additional Information
Bac-Off® is delivered as a 500X concentrate which, at working strength (1:500 v/v dilution in complete medium) exhibits Minimum Inhibitory Concentration (MIC) according to standard protocols against the listed species of microorganism.
Bac-Off® may also be used at double working strength (1:250 v/v) at which concentration it exhibits Minimum Bactericidal Concentration (MBC), which generally does not exceed the MIN by more than a factor of 2.
Bac-Off® may also be used at ten times working strength (1:50 v/v) at which concentration it exhibits mycoplasmacidal properties. This dosage is well tolerated by most mammalian cells in vitro for short periods of time.
Bac-Off® contains the synthetic fluoroquinone Ciprofloxacin, with a wide range of in vitro activity against a wide range of gram-negative and gram-positive microorganisms, specifically including the following:
Active against the following microorganisms:
Bacillus fragilis
Clostridium difficile
Staphylococcus spp
Staphylococcus haemolyticus
Staphylococcus epidermidis
Staphylococcus saprophyticus
Staphylococcus hominis
Streptococcus pneumoniae
Streptococcus pyogenes
Pseudomonas aeruginosa
Haemophilus influenzae
Haemophilus parainfluenzae
Enterococcus faecalis
Escherichia coli
Enterobacter spp.
Enterobacter cloacae
Enterobacter aerogenes
Citrobacter spp.
Citrobacter diversus
Citrobacter freundii
Klebsiella spp.
Klebsiella pneumoniae
Klebsiella oxytoca
Moraxella catarrhalis
Morganella morganii
Proteus spp.
Proteus mirabilis
Proteus vulgaris
Providencia Spp.
Providencia stuartii
Providencia rettgeri
Serratia marcescens
Acinetobacter Lwoffii
Aeromonas hydrophilia
Campyhlobacter jejuni
Edwardsiella tarda
Legionella pneumophilia
Neisseria gonorrhoeae
Salmonella spp.
Salmonella enteritidis
Salmonella typhii
Shigella spp.
Shigella dysenteriae
Shigella boydii
Shigella flexneri
Shigella sonnei
Vibrio spp.
Vibrio Cholerae
Vibrio vulnificus
Yersinia spp.
Yersinia enterocolitica
Yersinia pestis
Bacillus anthracis
The mechanism action of Bac-Off® is distinct from that of penicillins, cephaslosporins, aminoglycosides, macrolides, and tetracyclines. There are no reported instanxces of cross-resistance between Bac-Off® and other classes of antimicrobials. The inoculum size has little effect when tested in vitro.
The bacteriastastic (“working strength” 1:500) and bacteriacidal (“double strength” 1:250) activity of Bac-Off® results from inhibition of the bacterial enzymes topoisomerase II (DNA gyrase) and topoisomerase IV. These enzymes are necessary for bacterial replication, transcription, and repair. Mammalian topoisomerases are not affected by Bac-Off® at less than 7-10 fold working strength. This is a much wider “window” between the dosage active against bacterial growth and the dosage toxic to mammalian cells than all other commonly used antibiotic classes.
No application of sterile technique is 100% foolproof. Bac-Off® at working strength (MIC) is not acting as an antibiotic per se. Operationally it is, simply, a virtual certainty that no bacterial contamination will occur while Bac-Off® is in use.